Re: Not good for the potential of apabetalone as a Covid-19 therapy
in response to
by
posted on
Nov 29, 2021 03:26PM
Thanks Bear.
I am not a scientist but force myself to read most of this stuff. Do I not have reason to hang on to some optimism still given that the conclusion speaks to pan-BET inhibitors and that apabetalone is a BD-specific BET inhibitor?
''...our study urges caution with the clinical use, prophylactic or therapeutic, of pan-BET inhibitors in people at risk or afflicted with COVID-19."''